Anuh Pharma Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
2,641
2,804
3,206
2,061
2,381
Cost of Goods Sold (COGS) incl. D&A
2,307
2,435
2,738
1,632
2,034
Gross Income
334
369
468
430
347
SG&A Expense
105
96
144
214
149
EBIT
228
273
324
-
197
Unusual Expense
-
-
-
24
22
Non Operating Income/Expense
11
41
51
37
60
Interest Expense
1
9
9
7
5
Pretax Income
255
319
379
276
234
Income Tax
79
99
121
75
69
Consolidated Net Income
176
220
258
201
165
Net Income
176
220
258
201
165
Net Income After Extraordinaries
176
220
258
201
165
Net Income Available to Common
176
220
258
201
165
EPS (Basic)
7.02
8.78
10.30
8.00
6.59
Basic Shares Outstanding
25
25
25
25
25
EPS (Diluted)
7.02
8.78
10.30
8.00
6.59
Diluted Shares Outstanding
25
25
25
25
25
EBITDA
246
306
346
234
215
Other Operating Expense
-
-
1
1
1
Non-Operating Interest Income
16
15
13
8
4

About Anuh Pharma

View Profile
Address
3-A, Shivsagar Estate
Mumbai Maharashtra 400018
India
Employees -
Website http://www.anuhpharma.com
Updated 09/14/2018
Anuh Pharma Ltd. engages in the manufacturing of pharmaceuticals, medicinal chemical, and botanical products. It also produces macrolides, anti-TB, anti-bacterials, anti-malaria, and corticosteroids products. The company was founded on February 19, 1960 and is headquartered in Mumbai, India.